References
- Heisterkamp N., Groffen J. Molecular insight into the Philadelphia translocation. Haematologic Phatology 1991; 5: 1–10
- Ben Neriah Y., Daley G.Q., Mes-Messon A.M., Witte O.N., Baltimore D. The Chronic myeloid Leukemia specific p210 protein is the product of the BCR-ABL hybrid gene. Science 1984; 223: 212–214
- Hochhaus A., Reiter A., Skladny H., Melo J.V., Sick C., Berger U., Guo J.Q., Arlinghaus R.B., Hehlmann R., Goldman J.M., Cross N.C.P. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia negative chronic myelogenous leukemia. Blood 1996; 88: 2236–2240
- Maurer J., Janssen J.W.G., Thiel E., van Denderen J., Ludwig W-D, Aydemir U., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C.R. Detection of chimeric BCR - ABL genes in Acute Lymphoblastic Leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058
- Kawasaki E.S., Clark S.S., Coyne N.Y., Smith S.D., Champlin R., Witte O.N., McCormick F.P. Diagnosis of chronic myeloid and acute Lymphoblastic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proceedings of the National Academy of Sciences of the United States of America. 1988; 86: 5698–5702
- Negrin R.S., Blume K.G. The use of Polymerase chain reaction for the detection of Minimal residual malignant disease. Blood 1991; 78: 255–258
- Raanani P., Dazzi P., Sohal R., Szydlo R.M., van Rhee F., Reiter A., Lin F., Goldman J.M., Cross N.C. The rate and kinetics of molecular response to donor leukocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. British Journal of Haematology 1997; 99: 945–950
- Cross C.P.N., Melo J.V., Feng L., Goldman J.M. An Optimized Multiplex Polymerase Chain Reaction (PCR) for detection of BCR - ABL Fusion mRNAs in Haematological Disorders. Leukemia 1994; 8: 186–189
- Inokuchi K., Futaki M., Hanawa H., Tanosaki S., Yamaguchi H., Iwakiri R., Nomura T., Dan K. Heterogenous expression of bcr - abl fusion mRNA in patients with Philadelphia-chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology 1997; 97: 837–840
- Melo J.V., Myint H., Galton D.A.G., Goldman J.M. P190BCR-ABL chronic myeloid leukemia: the missing link with chronic myelomonocytic leukemia?. Leukemia 1994; 8: 208–211
- Hooberman A.L., Carrino J.J., Leibowitz D., Rowley J.D., Le Beau M.M., Arlin Z.A., Westbrpook C.A. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome- positive acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 4259–4263
- Kantarjian H.M., Dhingra K., Estey E., Keating M.J., Ku S., Trujillo J., Huh Y., Stass S., Kurzrock R. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411–2418
- Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M.R., Guerrasio A., de-Micheli D., Parziali A., Fornaci M.N., Martinelli G., Salvatore M. Consistent amounts of acute leukemia-associated P190 BCR / ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996; 87: 1075–1080
- van Rhee F., Hochhaus A., Lin F., Melo J.V., Goldman J.M., Cross N.C.P. P190 BCR / ABL mRNA is expressed at low levels in P210-positive chronic myeloid and acute lymphoblastic leukaemias. Blood 1996; 87: 5213–5217